BMEA
Biomea Fusion, Inc.
Biotechnology · Healthcare · United States
0.64
close · 2026-10-30
value
0
cheaper than peers0
quality
23
stronger fundamentals23
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 3.83× | 34 |
| earnings yield, latest year | -184.5% | 9 |
| cash flow yield, 3 years ago | -137.2% | 8 |
| cash flow yield, latest year | -152.2% | 8 |
| cash flow yield, 2 years ago | -216.2% | 7 |
| earnings yield, 3 years ago | -437.8% | 6 |
| cash flow yield, 1 year ago | -260.1% | 5 |
| earnings yield, 2 years ago | -537.9% | 3 |
| earnings yield, 1 year ago | -598.9% | 1 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| debt to equity | 7.2% | 43 |
| return on equity | -164.1% | 16 |
3 of 4 measures available
Facts
| market cap | $46M |
| free cash flow | -$27.8M |
| employees | 37 |
| first trade | 2021-04-16 |
| next earnings | not reported |
| fundamentals updated | 2026-08-14 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.18 | -3.83 | -3.44 | -2.80 |
| free cash flow | -$70.4M | -$120.3M | -$100.0M | -$63.4M |
| net income | -$61.8M | -$138.4M | -$117.3M | -$81.8M |
| revenue | $0 | $0 | $0 | $0 |
| unusual items | $17.7M | $0 | $0 | not reported |